a Clinical Risk Score to Predict Bloody Stool in Neonates
NCT ID: NCT05055817
Last Updated: 2023-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2021-10-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
NEC is one of the most serious disease in the newborn infants, and two and more grades of NEC might lead to surgery, even death. But, it is difficult to predict when the bloody stool comes and develop to two and more grades of NEC.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Score System of Surgery in Necrotizing Enterocolitis(NEC) Patients
NCT04795453
Significance of Ultrasound Combined with Near-Infrared Spectroscopy in Monitoring Transfusion-Associated Intestinal Injury in Extremely Preterm Infants: a Study Protocol for a Prospective, Observational Study
NCT06857812
Risk Factors for Poor Prognosis in Neonatal Necrotizing Enterocolitis
NCT07249697
Splanchnic Tissue Oxygenation During Enteral Feedings in Anemic Premature Infants at Risk for Necrotizing Enterocolitis
NCT01735578
Spectral Analysis of Bowel Sounds in Preterm Babies of Less Than 32 Weeks of Amenorrhea (WA) as Predictive Factor of Enterocolitis
NCT05544097
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Bloody stool in newborn infant is a urgent condition, and neonatologist usually need to predict whether or not two and more grades of NEC it is.
Here, the investigators will develop a score system in one retrospective cohort to predict bloody stool, and the score system is validated in another prospective cohort.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bloody stool group
bloody stool appear in the hospitalized neonate
bloody stool group
bloody stool appear in the hospitalized neonate
non-bloody stool group
bloody stool do not appear in the hospitalized neonate
non-bloody stool group
bloody stool do not appear in the hospitalized neonate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bloody stool group
bloody stool appear in the hospitalized neonate
non-bloody stool group
bloody stool do not appear in the hospitalized neonate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* less than or equal to 28 days
* non-neonatal intensive care unit ward
Exclusion Criteria
* main congenital malformation
1 Minute
28 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital of Chongqing Medical University
OTHER
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chen Long,MD
director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020204
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.